2m 2m 2m 2m 2m 2m 2m
Xenon Pharma (XENE)
NASDAQ
$38.06-$0.87 (-2.25%)
Price as of Oct 02, 2026 5:08 PM EDT- $3.8BMarket Cap
- -0.69%1-Year Change
- BiotechnologyIndustry
Xenon Pharma (XENE)
$38.06-$0.87 (-2.25%)
XENE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $38.93 | ||
Change | +$1.74 (+4.68%) | ||
Open | $38.31 | ||
High | $39.92 | ||
Low | $38.08 | ||
Previous Close | $37.19 | ||
Volume | 3,660,477 | ||
30-Day Average Volume | 2,380,250 | ||
1-Week Change | 2.29% | ||
1-Month Change | -35.12% | ||
1-Year Change | -0.69% | ||
3-Year Change | 13.96% | ||
5-Year Change | 149.55% | ||
Fundamentals | |||
Shares Outstanding | 96.8M | ||
Total Assets | $1.3B | ||
Market Cap | $3.8B | ||
Enterprise Value | $3.7B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$110.7M | ||
Free Cash Flow | -$95.7M | ||
EBIT | -$111.3M | ||
EBITDA | -$110.8M | ||
Net Working Capital | $900.9M | ||
EPS | -$1.11 | ||
Enterprise Value/EBITDA | -33 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -35 | ||
PEG | -7 | ||
Price/Free Cash Flow | -39 | ||
Price/Operating Cash Flow | -40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue